PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis

Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.800
https://www.valueinhealthjournal.com/article/S1098-3015(21)01017-2/fulltext
Title : PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01017-2&doi=10.1016/j.jval.2021.04.800
First page :
Section Title :
Open access? : No
Section Order : 10306
Categories :
Tags :
Regions :
ViH Article Tags :